ClearBridge Investments’s ANI Pharmaceuticals ANIP Stock Holding History

ClearBridge Investments’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-25	Closed	-$2K	–	1054
2019 Q4	$2K	Hold	25	–	–	﹤0.01%	1060
2019 Q3	$2K	Hold	25	–	–	﹤0.01%	1076
2019 Q2	$2K	Hold	25	–	–	﹤0.01%	1060
2019 Q1	$2K	Hold	25	–	–	﹤0.01%	1050
2018 Q4	$1K	Hold	25	–	–	﹤0.01%	1106
2018 Q3	$1K	Hold	25	–	–	﹤0.01%	1116
2018 Q2	$2K	Hold	25	–	–	﹤0.01%	1086
2018 Q1	$1K	Hold	25	–	–	﹤0.01%	1117
2017 Q4	$2K	Hold	25	–	–	﹤0.01%	1099
2017 Q3	$1K	Buy	+25	New	+$1.19K	﹤0.01%	1162
2013 Q3	–	Sell	-25	Closed	-$1K	–	1088
2013 Q2	$1K	Buy	+25	New	+$175	﹤0.01%	1061

Other funds holding ANIP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ICOM

Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

ClearBridge Investments's ANIP Position: Q1 2020 in Review

ClearBridge Investments sold out of ANI Pharmaceuticals (ANIP) in Q1 2020, closing a stake of 25 shares — an estimated $2K sold.

ClearBridge Investments first reported a position in ANIP in Q2 2013 and held it in 11 quarters. The position peaked at $2K in Q4 2019. 140 funds tracked by Wall St. Rank hold ANIP as of Q1 2020.

ClearBridge Investments reported no remaining ANI Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
ClearBridge Investments sold 25 ANI Pharmaceuticals shares in Q1 2020, an estimated $2K.
ClearBridge Investments first reported a position in ANI Pharmaceuticals in Q2 2013 and held it in 11 quarters.
ClearBridge Investments's ANI Pharmaceuticals position peaked at $2K in Q4 2019.
140 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2020.

Based on ClearBridge Investments's 13F filing for Q1 2020, filed 15 May 2020.